Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 PART I, 1998, Pages 1328-1331

  Juffermans, Nicole P ^a   Verbon, Annelies ^b   Van Deventer, Sander J H ^b   Van Deutekom, Henk ^b   Speelman, Peter ^b   Van Der Poll, Tom ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; TUBERCULOSIS;

EID: 0031958198     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.9709126     Document Type: Article

References (21)

1. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. J.A.M.A. 273:220-226.
2. Cooper, A. M., and J. L. Flynn. 1995. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 7:512-516.
3. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
4. Denis, M., and E. Ghadirian. 1994. lnterleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect. Immun. 62:457-461.
5. van der Poll, T., and S. F. Lowry. 1995. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3:1-12.
6. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
7. Giri, J. G., J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims, and M. R. Alderson. 1994. Elevated levels of shed type II IL-1 receptor in sepsis: potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153:5802-5809.
8. van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175: 118-122.
9. Altman, D. G. 1991. Practical Statistics for Medical Research. Fourth edition. Chapman & Hall, London. 194-197.
10. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:4845-4849.
11. Girardin, E., P. Roux-Lombard, G. E. Grau, P. Suter, H. Gallati, and J. M. Dayer. 1992. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology 76:20-23.
12. Godfried, M. H., T. van der Poll, J. Jansen, J. A. Romijin, J. K. Schattenkerk, E. Endert, S. J. van Deventer, and H. P. Sauerwein. 1993. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7:33-36.
13. Zijlstra, E. E., T. van der Poll, and M. Mevissen. 1995. Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis. J. Infect. Dis. 171:498-501.
14. Barnes, P. F., S. J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J. Immunol. 145:149-154.
15. Law, K., M. Weiden, T. Harkin, K. Tchou-Wong, C. Chi, and W. N. Rom. 1996. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153:799-804.
16. Takashima, T., C. Ueta, I. Tsuyuguchi, and S. Kishimoto. 1990. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect. Immun. 58:3286-3292.
17. Cadranel, J., C. Philippe, J. Perez, B. Milleron, G. Akoun, R. Ardaillou, and L. Baud. 1990. In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients. Clin. Exp. Immunol. 81:319-324.
18. Rydberg, J., H. Miorner, A. Chandramuki, and M. Lantz. 1995. Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system. J. Infect. Dis. 172:301-304.
19. Pruitt, J. H., M. B. Welborn, P. D. Edwards, T. R. Harward, J. W. Seeger, T. D. Martin, C. Smith, J. A. Kenney, R. I. Wesdorp, S. Meijer, M. A. Cuesta, A. Abouhanze, E. M. Copeland, III, J. Giri, J. E. Sims, L. L. Moldawer, and H. S. Oldenburg. 1996. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-3288.
20. Fischer, E., K. J. Van Zec, M. A. Marano, C. S. Rock, J. S. Kenney, D. D. Poutsiaka, C. A. Dinarello, S. F. Lowry, and L. L. Moldawer. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200.
21. Shimokata, K., H. Saka, T. Murate, Y. Hasegawa, and T. Hasegawa. 1991. Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest 99:1103-1107.